Safety, efficacy, and pharmacokinetics of a single-tablet regimen containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in treatment-naive, HIV-infected adolescents: a single-arm, open-label trial. [electronic resource]
Producer: 20170609Description: e561-e568 p. digitalISSN:- 2352-3018
- Adenine -- administration & dosage
- Adolescent
- Alanine
- Anti-HIV Agents -- administration & dosage
- Area Under Curve
- CD4 Lymphocyte Count
- Child
- Cobicistat -- administration & dosage
- Drug Therapy, Combination
- Emtricitabine -- administration & dosage
- Female
- HIV Infections -- drug therapy
- HIV-1 -- genetics
- Humans
- Lost to Follow-Up
- Male
- Quinolones -- administration & dosage
- RNA, Viral -- blood
- South Africa -- epidemiology
- Tablets
- Tenofovir -- analogs & derivatives
- Thailand -- epidemiology
- Uganda -- epidemiology
- United States -- epidemiology
- Viral Load
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.